How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop

David Kirkland(Covance (United Kingdom)), Paul A. White(Health Canada), Stephan Kirchner(Roche (Switzerland)), Stefan Pfuhler(Procter & Gamble (Switzerland)), Philippe Vanparys, Azeddine Elhajouji(Novartis (Switzerland)), Paul W. Hastwell(GlaxoSmithKline (United Kingdom)), F. Darroudi(Leiden University), Daniela Maurici(Joint Research Centre), Hansruedi Glatt(German Institute of Human Nutrition), Jean-Roc Meunier(L'Oréal (France)), Marilyn J. Aardema(Procter & Gamble (United States)), Makoto Hayashi(National Institute of Health Sciences), James M. Parry(University of Wales), Jan van Benthem(National Institute for Public Health and the Environment), Elizabeth M. Parry(University of Wales), Ray Tice(Research Triangle Park Foundation), Daniel Marzin(Institut Pasteur de Lille), Peter Kasper(Federal Institute for Drugs and Medical Devices), Anthony Lynch(GlaxoSmithKline (United Kingdom)), Lutz Müller(Roche (Switzerland)), David Tweats(Swansea University), Gerhard J. Nohynek(L'Oréal (France)), Véronique Thybaud(Sanofi (France)), Raffaella Corvi(Joint Research Centre)
Mutation Research/Genetic Toxicology and Environmental Mutagenesis
January 14, 2007
Cited by 437


Related Papers